Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Extrapulmonary Presentations of COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04896762
Recruitment Status : Recruiting
First Posted : May 21, 2021
Last Update Posted : May 21, 2021
Sponsor:
Information provided by (Responsible Party):
Hend Mohammed Abdelraheem Esmaeel, Sohag University

Brief Summary:
An observational study about the extrapulmonary presentations of COVID-19 patients during the second wave of the pandemic.

Condition or disease
COVID-19

Detailed Description:

a prospective observational study that aimed at

  1. provide an overview about the prevalence of extra-pulmonary presentation of COVID-19 during the second wave of the pandemic and
  2. Detection of the most frequent affected systems with comparison between the pulmonary and extrapulmonary presentation of COVID 19 as regard patient demographics, comorbidity and level of care needed.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Extrapulmonary Presentation of COVID-19 Patients During the Second Wave
Actual Study Start Date : September 1, 2020
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : October 2021

Resource links provided by the National Library of Medicine


Group/Cohort
Extrapulmonary presentation for COVID-19
patients with confirmed covid 19 disease who primarily presented with extrapulmonary system affection
pulmonary presentation for COVID-19
patients with confirmed covid 19 disease who primarily presented with pulmonary disease



Primary Outcome Measures :
  1. extrapulmonary presentation in COVID-19 [ Time Frame: Baseline presentation of confirmed cases with COVID-19 ]
    frequency of extrapulmonary presentation inCOVID-19 second wave pandemic



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients presented at a triage point in a tertiary health care facility with a suspected covid 19 disease.
Criteria

Inclusion Criteria:

  • all patient with confirmed covid 19 disease presented to our health facility during the second wave of the pandemic

Exclusion Criteria:

  • other diagnosis than covid 19 as a primary cause of presentation of the patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04896762


Contacts
Layout table for location contacts
Contact: hend mohamed A esmaeel, MD 01009470158 hendomr@gmail.com

Locations
Layout table for location information
Egypt
Sohag University Recruiting
Sohag, Egypt, 82425
Contact: hend mohamed A esmaeel    01009470158    hendomr@gmail.com   
Sponsors and Collaborators
Sohag University
Publications:
Layout table for additonal information
Responsible Party: Hend Mohammed Abdelraheem Esmaeel, assistant professor, Sohag University
ClinicalTrials.gov Identifier: NCT04896762    
Other Study ID Numbers: Soh-Med-21-04-25
First Posted: May 21, 2021    Key Record Dates
Last Update Posted: May 21, 2021
Last Verified: May 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Hend Mohammed Abdelraheem Esmaeel, Sohag University:
extrapulmonary presentation
pulmonary
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases